Tocilizumab in COVID-19 management: addressing time of starting treatment | European Journal of Hospital Pharmacy

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PostScript

Letter

Tocilizumab in COVID-19 management: addressing time of starting treatment

Online download statistics by month:

Online download statistics by month: January 2022 to March 2024

	Abstract	Full	Pdf
Jan 2022	450	443	75
Feb 2022	166	163	32
Mar 2022	124	120	19
Apr 2022	107	105	20
May 2022	102	100	25
Jun 2022	90	89	11
Jul 2022	84	84	8
Aug 2022	101	101	7
Sep 2022	98	98	13
Oct 2022	90	90	19
Nov 2022	80	80	13
Dec 2022	83	82	4
Jan 2023	89	89	6
Feb 2023	165	164	10
Mar 2023	331	338	31
Apr 2023	234	234	21
May 2023	75	74	7
Jun 2023	72	73	6
Jul 2023	67	63	10
Aug 2023	90	90	12
Sep 2023	64	53	10
Oct 2023	74	62	7
Nov 2023	49	38	3
Dec 2023	16	16	5
Jan 2024	16	16	11
Feb 2024	29	8	3
Mar 2024	137	2	4
Total	3083	2875	392